1  791 135 EFFECT OF YOGA EXERCISE THERAPY ON OXIDATIVE STRESS INDICATORS WITH END-STAGE RENAL DISEASE ON HEMODIALYSIS. BACKGROUND: OXIDATIVE STRESS PROMOTES ENDOTHELIAL DYSFUNCTION AND ATHEROSCLEROSIS IN CHRONIC RENAL DISEASE. OBJECTIVES: THIS STUDY INVESTIGATED THE IMPACT OF HATHA YOGA ON OXIDATIVE STRESS INDICATORS AND OXIDANT STATUS, IN PATIENTS WITH END-STAGE RENAL DISEASE (ESRD) ON HEMODIALYSIS. DESIGN: THIS PROSPECTIVE RANDOMIZED STUDY CONSISTED OF 33 ESRD PATIENTS IN THE HATHA YOGA EXERCISE GROUP WHO WERE MATCHED WITH 35 ESRD PATIENTS IN THE CONTROL GROUP. OUTCOME MEASURES: THE OXIDATIVE STRESS INDICATORS (MALONDIALDEHYDE - MDA, PROTEIN OXIDATION - POX, PHOSPHOLIPASE A2 - PLA2 ACTIVITY) AND THE OXIDATIVE STATUS (SUPEROXIDE DISMUTASE (SOD) AND CATALASE ACTIVITIES) WERE DETERMINED IN THE BLOOD SAMPLES TAKEN AT THE PRE-HEMODIALYSIS TREATMENT, AT BASELINE (0 MONTHS) AND AFTER FOUR MONTHS. RESULTS: IN PATIENTS IN THE HATHA YOGA EXERCISE GROUP, LIPID PEROXIDATION, AS INDICATED BY MDA DECREASED BY 4.0% AFTER FOUR MONTHS (P = 0.096). THERE WAS ALSO A SIGNIFICANT REDUCTION IN THE ACTIVITY OF PLA FROM 2.68 +/- 0.02 IU / L TO 2.34 IU / L (- 12.7%; P = 0.010) AND POX FROM 2.28 +/- 0.02 NMOL / MG TO 2.22 +/- 0.01 NMOL / MG (- 22.6%; P = 0.0001). THE ACTIVITY OF SOD SIGNIFICANTLY INCREASED FROM 12.91 +/- 0.17 U / L TO 13.54 +/- 0.15 U / L (4.65%; P = 0.0001) AND CATALASE FROM 79.83 +/- 0.63 U / L TO 80.54 +/- 0.80 U / L (0.90%; P = 0.0001). THERE WAS A SIGNIFICANT CORRELATION BETWEEN THE PRE-HEMODIALYSIS OXIDATIVE STRESS PARAMETERS AT THE ZERO MONTH AND AFTER FOUR MONTHS FOR THE ACTIVITIES OF PLA (R = 0.440), CATALASE (R = 0.872), AND SOD (R = 0.775). CONCLUSIONS: THESE FINDINGS SUGGEST THAT THE HATHA YOGA EXERCISE HAS THERAPEUTIC, PREVENTATIVE, AND PROTECTIVE EFFECTS IN ESRD SUBJECTS, BY DECREASING OXIDATIVE STRESS.	2013	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
2   90  35 A MODIFIED YOGA-BASED EXERCISE PROGRAM IN HEMODIALYSIS PATIENTS: A RANDOMIZED CONTROLLED STUDY. AIM: TO EVALUATE THE EFFECTS OF A YOGA-BASED EXERCISE PROGRAM ON PAIN, FATIGUE, SLEEP DISTURBANCE, AND BIOCHEMICAL MARKERS IN HEMODIALYSIS PATIENTS. MATERIALS AND METHODS: IN 2004 A RANDOMIZED CONTROLLED TRIAL WAS CARRIED OUT IN THE OUTPATIENT HEMODIALYSIS UNIT OF THE NEPHROLOGY DEPARTMENT, ULUDAG UNIVERSITY FACULTY OF MEDICINE. CLINICALLY STABLE HEMODIALYSIS PATIENTS (N=37) WERE INCLUDED AND FOLLOWED IN TWO GROUPS: THE MODIFIED YOGA-BASED EXERCISE GROUP (N=19) AND THE CONTROL GROUP (N=18). YOGA-BASED EXERCISES WERE DONE IN GROUPS FOR 30 MIN/DAY TWICE A WEEK FOR 3 MONTHS. ALL OF THE PATIENTS IN THE YOGA AND CONTROL GROUPS WERE GIVEN AN ACTIVE RANGE OF MOTION EXERCISES TO DO FOR 10 MIN AT HOME. THE MAIN OUTCOME MEASURES WERE PAIN INTENSITY (MEASURED BY THE VISUAL ANALOGUE SCALE, VAS), FATIGUE (VAS), SLEEP DISTURBANCE (VAS), AND GRIP STRENGTH (MMHG); BIOCHEMICAL VARIABLES-- UREA, CREATININE, CALCIUM, ALKALINE PHOSPHATASE, PHOSPHORUS, CHOLESTEROL, HDL-CHOLESTEROL, TRIGLYCERIDE, ERYTHROCYTE, HEMATOCRIT--WERE EVALUATED. RESULTS: AFTER A 12-WEEK INTERVENTION, SIGNIFICANT IMPROVEMENTS WERE SEEN IN THE VARIABLES: PAIN -37%, FATIGUE -55%, SLEEP DISTURBANCE -25%, GRIP STRENGTH +15%, UREA -29%, CREATININE -14%, ALKALINE PHOSPHATASE -15%, CHOLESTEROL -15%, ERYTHROCYTE +11%, AND HEMATOCRIT COUNT +13%; NO SIDE-EFFECTS WERE SEEN. IMPROVEMENT OF THE VARIABLES IN THE YOGA-BASED EXERCISE PROGRAM WAS FOUND TO BE SUPERIOR TO THAT IN THE CONTROL GROUP FOR ALL THE VARIABLES EXCEPT CALCIUM, PHOSPHORUS, HDL-CHOLESTEROL AND TRIGLYCERIDE LEVELS. CONCLUSION: A SIMPLIFIED YOGA-BASED REHABILITATION PROGRAM IS A COMPLEMENTARY, SAFE AND EFFECTIVE CLINICAL TREATMENT MODALITY IN PATIENTS WITH END-STAGE RENAL DISEASE.	2007	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
3  765  38 EFFECT OF THE INTEGRATED APPROACH OF YOGA THERAPY ON PLATELET COUNT AND URIC ACID IN PREGNANCY: A MULTICENTER STRATIFIED RANDOMIZED SINGLE-BLIND STUDY. BACKGROUND: YOGA IMPROVES MATERNAL AND FETAL OUTCOMES IN PREGNANCY. PLATELET COUNT AND URIC ACID (UA) ARE VALUABLE SCREENING MEASURES IN HIGH-RISK PREGNANCY. AIM: TO EXAMINE THE EFFECT OF YOGA ON PLATELET COUNTS AND SERUM UA IN HIGH-RISK PREGNANCY. MATERIALS AND METHODS: THIS STRATIFIED RANDOMIZED CONTROLLED TRIAL, CONDUCTED BY S-VYASA UNIVERSITY AT ST. JOHN'S MEDICAL COLLEGE HOSPITAL AND GUNASHEELA MATERNITY HOSPITAL, RECRUITED 68 WOMEN WITH HIGH-RISK PREGNANCY (30 YOGA AND 38 CONTROLS) IN THE TWELFTH WEEK OF PREGNANCY. THE INCLUSION CRITERIA WERE: BAD OBSTETRICS HISTORY, TWIN PREGNANCIES, MATERNAL AGE < 20 OR > 35 YEARS, OBESITY (BMI > 30), AND GENETIC HISTORY OF PREGNANCY COMPLICATIONS. THOSE WITH NORMAL PREGNANCY, ANEMIA (< 10 GRAMS%DL), H/O CLOTTING DISORDERS; RENAL, HEPATIC OR HEART DISEASE; SEIZURE DISORDER; OR STRUCTURAL ABNORMALITIES IN THE PELVIS, WERE EXCLUDED. THE YOGA GROUP PRACTICED SIMPLE MEDITATIVE YOGA (THREE DAYS / WEEK FOR THREE MONTHS). RESULTS: AT BASELINE, ALL WOMEN HAD NORMAL PLATELET COUNTS (> 150X10(9)/L) WITH A DECREASE AS PREGNANCY ADVANCED. UA (NORMAL AT BASELINE) INCREASED IN BOTH GROUPS. NO ONE DEVELOPED ABNORMAL THROMBOCYTOPENIA OR HYPERURICEMIA. HEALTHY REDUCTION IN PLATELET COUNT (TWELFTH TO TWENTIETH WEEK) OCCURRED IN A HIGHER (P < 0.001, CHI(2) TEST) NUMBER OF WOMEN IN THE YOGA GROUP THAN THE CONTROL GROUP. A SIMILAR TREND WAS FOUND IN URIC ACID. SIGNIFICANTLY LESSER NUMBER OF WOMEN IN THE YOGA GROUP (N = 3) DEVELOPED PREGNANCY-INDUCED HYPERTENSION (PIH) / PRE-ECLAMPSIA (PE) THAN THOSE IN THE CONTROL GROUP (N = 12), WITH ABSOLUTE RISK REDUCTION (ARR) BY 21%. CONCLUSION: ANTENATAL INTEGRATED YOGA FROM THE TWELFTH WEEK IS SAFE AND EFFECTIVE IN PROMOTING A HEALTHY PROGRESSION OF PLATELETS AND URIC ACID IN WOMEN WITH HIGH-RISK PREGNANCY, POINTING TO HEALTHY HEMODILUTION AND BETTER PHYSIOLOGICAL ADAPTATION.	2013	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
4  838  26 EFFECT OF YOGA ON PHYSICAL AND PSYCHOLOGICAL OUTCOMES IN PATIENTS ON CHRONIC HEMODIALYSIS. INTRODUCTION: PATIENTS ON CHRONIC HEMODIALYSIS SUFFER FROM A MYRIAD OF PROBLEMS ASSOCIATED WITH DIALYSIS INCLUDING INCREASED CARDIOVASCULAR DISEASE, DECONDITIONING, FATIGUE, SLEEP DISTURBANCES, ANXIETY AND DEPRESSION, AND DECREASED HEALTH RELATED QUALITY OF LIFE. YOGA HAS BEEN REPORTED TO HAVE POSITIVE EFFECTS ON DISTRESS AND FUNCTIONAL PERFORMANCE IN PATIENTS WITH CHRONIC DISEASES. THE EFFECT OF YOGA IN PATIENTS ON CHRONIC HEMODIALYSIS IS UNKNOWN. FOR THE PURPOSE OF THIS STUDY, PAPERS WERE REVIEWED TO DETERMINE THE EFFECT OF INTRADIALYSIS YOGA ON DISTRESS AND FUNCTIONAL PERFORMANCE IN PATIENTS UNDERGOING CHRONIC HEMODIALYSIS. METHODS: THIS INTEGRATIVE REVIEW EXAMINED STUDIES PUBLISHED IN PUBMED, CINAHL AND PSYCHINFO. THE SEARCH TERMS INCLUDED: YOGA, HEMODIALYSIS, DIALYSIS. RESULTS: TWO RCTS MET THE CRITERIA. YOGA SHOWED IMPROVEMENT IN SEVERAL OUTCOMES INCLUDING: QUALITY OF LIFE, PAIN, FATIGUE, SLEEP DISTURBANCE, PHYSICAL FUNCTION AS WELL AS A NUMBER OF BIOCHEMICAL VARIABLES. FURTHER WELL DESIGNED RCTS NEED TO BE CONDUCTED.	2019	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
5 1235  36 FEASIBILITY AND SAFETY OF INTRADIALYSIS YOGA AND EDUCATION IN MAINTENANCE HEMODIALYSIS PATIENTS. OBJECTIVE: PATIENTS WITH END-STAGE RENAL DISEASE ON MAINTENANCE HEMODIALYSIS ARE MUCH MORE SEDENTARY THAN HEALTHY INDIVIDUALS. THE PURPOSE OF THIS STUDY WAS TO ASSESS THE FEASIBILITY AND SAFETY OF A 12-WEEK INTRADIALYSIS YOGA INTERVENTION VERSUS A KIDNEY EDUCATION INTERVENTION ON THE PROMOTION OF PHYSICAL ACTIVITY. DESIGN AND METHODS: WE RANDOMIZED PARTICIPANTS BY DIALYSIS SHIFT TO EITHER 12-WEEK INTRADIALYSIS YOGA OR AN EDUCATIONAL INTERVENTION. INTRADIALYSIS YOGA WAS PROVIDED BY YOGA TEACHERS TO PARTICIPANTS WHILE RECEIVING HEMODIALYSIS. PARTICIPANTS RECEIVING THE 12-WEEK EDUCATIONAL INTERVENTION RECEIVED A MODIFICATION OF A PREVIOUSLY DEVELOPED COMPREHENSIVE EDUCATIONAL PROGRAM FOR PATIENTS WITH KIDNEY DISEASE (KIDNEY SCHOOL). THE PRIMARY OUTCOME FOR THIS STUDY WAS FEASIBILITY BASED ON RECRUITMENT AND ADHERENCE TO THE INTERVENTIONS AND SAFETY OF INTRADIALYSIS YOGA. SECONDARY OUTCOMES WERE TO DETERMINE THE FEASIBILITY OF ADMINISTERING QUESTIONNAIRES AT BASELINE AND 12 WEEKS INCLUDING THE KIDNEY DISEASE-RELATED QUALITY OF LIFE-36. RESULTS: AMONG 56 ELIGIBLE PATIENTS WHO APPROACHED FOR THE STUDY, 31 (55%) WERE INTERESTED AND CONSENTED TO PARTICIPATION, WITH 18 ASSIGNED TO INTRADIALYSIS YOGA AND 13 TO THE EDUCATIONAL PROGRAM. A TOTAL OF 5 PARTICIPANTS WITHDREW FROM THE PILOT STUDY, ALL FROM THE INTRADIALYSIS YOGA GROUP. TWO OF THESE PARTICIPANTS REPORTED NO FURTHER INTEREST IN PARTICIPATION. THREE WITHDRAWN PARTICIPANTS SWITCHED DIALYSIS TIMES AND THEREFORE COULD NO LONGER RECEIVE INTRADIALYSIS YOGA. AS A RESULT, 13 OF 18 (72%) AND 13 OF 13 (100%) PARTICIPANTS COMPLETED 12-WEEK INTRADIALYSIS YOGA AND EDUCATIONAL PROGRAMS, RESPECTIVELY. THERE WERE NO ADVERSE EVENTS RELATED TO INTRADIALYSIS YOGA. INTERVENTION PARTICIPANTS PRACTICED YOGA FOR A MEDIAN OF 21 SESSIONS (70% PARTICIPATION FREQUENCY), WITH 60% OF PARTICIPANTS PRACTICING AT LEAST 2 TIMES A WEEK. PARTICIPANTS IN THE EDUCATIONAL PROGRAM COMPLETED A MEDIAN OF 30 SESSIONS (83% PARTICIPATION FREQUENCY). OF PARTICIPANTS WHO COMPLETED THE STUDY (N = 26), BASELINE AND 12-WEEK QUESTIONNAIRES WERE OBTAINED FROM 85%. CONCLUSIONS: OUR PILOT STUDY OF 12-WEEK INTRADIALYSIS YOGA AND 12-WEEK EDUCATIONAL INTERVENTION REACHED RECRUITMENT GOALS BUT WITH LESS THAN TARGETED COMPLETION AND ADHERENCE TO INTERVENTION RATES. THIS STUDY PROVIDED VALUABLE FEASIBILITY DATA TO INCREASE FOLLOW-UP AND ADHERENCE FOR FUTURE CLINICAL TRIALS TO COMPARE EFFICACY.	2015	
                                                                                                                                                                                                                             
6 1001  27 EFFECTS OF LAUGHTER YOGA ON HEMODIALYSIS PATIENTS' PLASMA-BETA ENDORPHIN LEVELS, PAIN LEVELS AND SLEEP QUALITY: A RANDOMIZED CONTROLLED TRIAL. THIS STUDY EVALUATES THE EFFECTS OF "LAUGHTER YOGA" ON THE PLASMA BETA-ENDORPHIN LEVELS, PAIN LEVELS AND SLEEP QUALITY OF HEMODIALYSIS PATIENTS. IT IS A RANDOMIZED CONTROLLED TRIAL. THE STUDY WAS CARRIED OUT BETWEEN JULY AND OCTOBER 2018. A TOTAL OF 68 PATIENTS RECEIVING HEMODIALYSIS TREATMENT AT TWO DIFFERENT DIALYSIS CENTERS WERE INCLUDED IN THE STUDY. THE DURATION OF THE LAUGHTER YOGA WAS 30 MIN, AND A TOTAL OF 16 SESSIONS WERE PERFORMED ON A TWICE-WEEKLY BASIS. THE DATA WERE COLLECTED BY USING A SOCIO-DEMOGRAPHIC INFORMATION FORM, THE VISUAL ANALOG SCALE AND THE PITTSBURGH SLEEP QUALITY INDEX, AND BLOOD SAMPLES WERE COLLECTED TO DETERMINE BETA-ENDORPHIN LEVELS. FOLLOWING THE LAUGHTER YOGA IMPLEMENTATION, THE PAIN LEVEL OF THE INTERVENTION GROUP PATIENTS SIGNIFICANTLY DECREASED, AND THEIR SLEEP QUALITY SIGNIFICANTLY IMPROVED. NO SIGNIFICANT CHANGE OCCURRED IN THE PATIENTS' BETA-ENDORPHIN LEVELS. LAUGHTER YOGA WAS EFFECTIVE IN REDUCING PAIN AND INCREASING SLEEP QUALITY.	2021	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
7  986  34 EFFECTS OF HATHA YOGA EXERCISE ON PLASMA MALONDIALDEHYDE CONCENTRATION AND SUPEROXIDE DISMUTASE ACTIVITY IN FEMALE PATIENTS WITH SHOULDER PAIN. [PURPOSE] THE PURPOSE OF THIS STUDY WAS TO ANALYZE THE EFFECTS OF HATHA YOGA EXERCISE ON PLASMA MALONDIALDEHYDE (MDA) CONCENTRATION AND SUPEROXIDE DISMUTASE (SOD) ACTIVITY IN FEMALE PATIENTS WITH SHOULDER PAIN. [SUBJECTS] SUBJECTS COMPRISED 20 FEMALE PATIENTS WITH SHOULDER PAIN. [METHODS] SUBJECTS WERE DIVIDED INTO 2 GROUPS: A HATHA YOGA EXERCISE GROUP (N = 10) AND A CONTROL GROUP THAT PERFORMED NO EXERCISE (N = 10). THE SUBJECTS' BODY COMPOSITION, PLASMA MALONDIALDEHYDE CONCENTRATIONS, AND SUPEROXIDE DISMUTASE ACTIVITIES WERE MEASURED BEFORE AND AFTER A 16-WEEK HATHA YOGA EXERCISE PROGRAM. [RESULTS] AFTER THE 16-WEEK HATHA YOGA EXERCISE PROGRAM, THE EXERCISE GROUP HAD SIGNIFICANTLY LOWER PLASMA MDA CONCENTRATIONS THAN THE CONTROL GROUP. IN ADDITION, THE EXERCISE GROUP HAD SIGNIFICANTLY HIGHER PLASMA SOD ACTIVITY THAN THE CONTROL GROUP. [CONCLUSIONS] HATHA YOGA EXERCISE IMPROVES FLEXIBILITY, MUSCLE TONE AND STRENGTH, BALANCE, AND JOINT FUNCTION. OUR FINDINGS INDICATE THAT REGULAR AND CONTINUOUS YOGA EXERCISE EFFECTIVELY IMPROVED BODY COMPOSITION, DECREASE PLASMA MDA CONCENTRATION, AND INCREASE PLASMA SOD ACTIVITY IN FEMALE PATIENTS WITH SHOULDER PAIN.	2015	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
8  940  38 EFFECTS OF 6 MONTHS YOGA PROGRAM ON RENAL FUNCTIONS AND QUALITY OF LIFE IN PATIENTS SUFFERING FROM CHRONIC KIDNEY DISEASE. AIM: TO STUDY THE EFFECT OF 6 MONTHS YOGA PROGRAM IN PATIENTS SUFFERING FROM CHRONIC KIDNEY DISEASE (CKD). MATERIALS AND METHODS: FIFTY-FOUR PATIENTS WITH CKD WERE STUDIED AND DIVIDED INTO TWO GROUPS (YOGA GROUP AND CONTROL GROUP) TO SEE THE EFFECT OF YOGA IN CKD. PATIENTS IN THE YOGA GROUP WERE OFFERED YOGA THERAPY ALONG WITH OTHER CONVENTIONAL TREATMENT MODALITIES, WHILE THE CONTROL GROUP WAS ONLY ON CONVENTIONAL TREATMENT. SUBJECTS IN YOGA GROUP WERE TRAINED TO PERFORM SPECIFIC YOGIC ASANAS FOR AT LEAST 5 DAYS A WEEK FOR 40-60 MIN A DAY. REGULAR MONITORING OF BLOOD PRESSURE, RENAL FUNCTION, REQUIREMENT OF A NUMBER OF DIALYSIS, AND QUALITY OF LIFE (QOL) INDICATORS WERE DONE. FIFTY PATIENTS (YOGA - 25; CONTROL-25) COMPLETED 6 MONTHS FOLLOW-UP. RESULTS: IN YOGA GROUP, A SIGNIFICANT REDUCTION OF SYSTOLIC AND DIASTOLIC BLOOD PRESSURE, SIGNIFICANT REDUCTION IN BLOOD UREA AND SERUM CREATININE LEVELS, AND SIGNIFICANT IMPROVEMENT IN PHYSICAL AND PSYCHOLOGICAL DOMAIN OF THE WORLD HEALTH ORGANIZATION QOL (AS ASSESSED BY BREF QOL SCORES) WERE SEEN AFTER 6 MONTHS. IN CONTROL GROUP, RISE OF BLOOD PRESSURE, DETERIORATION OF RENAL FUNCTION, AND QOL WERE OBSERVED. POSTSTUDY COMPARISON BETWEEN THE TWO GROUPS SHOWED A STATISTICALLY SIGNIFICANT REDUCTION OF BLOOD PRESSURE, NONSIGNIFICANT REDUCTION IN BLOOD UREA AND SERUM CREATININE, AND SIGNIFICANT IMPROVEMENT IN PHYSICAL AND PSYCHOLOGICAL DOMAIN OF QOL IN YOGA GROUP AS COMPARED TO CONTROL GROUP. FOR SUBJECTS IN YOGA GROUP, THE NEED FOR DIALYSIS WAS LESS WHEN COMPARED TO CONTROL GROUP ALTHOUGH THIS DIFFERENCE WAS STATISTICALLY INSIGNIFICANT. EXCEPT FOR INABILITY OF SOME PATIENTS TO PERFORM CERTAIN YOGIC ASANAS NO ADVERSE EFFECT WAS FOUND IN THE STUDY. CONCLUSION: SIX MONTHS YOGA PROGRAM IS SAFE AND EFFECTIVE AS AN ADJUVANT THERAPY IN IMPROVING RENAL FUNCTIONS AND QOL OF CKD PATIENTS.	2017	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
9 1783  30 PREDICTORS OF HEALTH-RELATED QUALITY OF LIFE IN INDIANS WITH METABOLIC SYNDROME UNDERGOING RANDOMIZED CONTROLLED TRIAL OF YOGA-BASED LIFESTYLE INTERVENTION VS DIETARY INTERVENTION. THE PRESENT STUDY EXPLORES THE EFFICACY OF 12-WEEK YOGA + DIET-BASED LIFESTYLE INTERVENTION (YBLI) VS DIETARY INTERVENTION (DI) ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) AND IDENTIFIES THE PREDICTORS OF CHANGE IN HRQOL IN INDIANS WITH METABOLIC SYNDROME (MET S). DATA FROM THE HISTORICAL RANDOMIZED CONTROLLED TRIAL WAS USED INCLUDING ADULTS (N = 260, 20-45 YEARS) WITH MET S. FOUR DOMAINS OF HRQOL WERE MEASURED AT BASELINE, 2 AND 12 WEEKS USING WHOQOL-BREF QUESTIONNAIRE. GENERALIZED ESTIMATING EQUATION AND CHI-SQUARE TEST WAS USED TO COMPARE 12-WEEK CHANGES IN HRQOL DOMAINS AND PROPORTION OF SUBJECTS, RESPECTIVELY. CHANGES IN HRQOL WERE PREDICTED USING REGRESSION MODELS CONCERNING CHANGES IN BODY MASS INDEX (BMI), PHYSICAL ACTIVITY, TOTAL CALORIE INTAKE, ADIPONECTIN, AND SUPEROXIDE DISMUTASE (SOD) LEVELS. EXPLORATORY MEDIATION ANALYSIS WAS CARRIED OUT USING BARON & KENNY APPROACH. YBLI RESULTED IN A SIGNIFICANTLY GREATER INCREASE IN THE PHYSICAL DOMAIN SCORE OF HRQOL THAN DI. A SIGNIFICANTLY GREATER PROPORTION OF SUBJECTS IN YBLI GROUP (71%) SHOWED AN INCREASE IN PHYSICAL DOMAIN SCORES COMPARED TO DI (51%). A UNIT CHANGE IN BMI NEGATIVELY PREDICTED A UNIT CHANGE IN PHYSICAL, PSYCHOLOGICAL AND ENVIRONMENTAL HEALTH. WHEREAS, A UNIT CHANGE IN ADIPONECTIN AND SOD LEVELS POSITIVELY PREDICTED A UNIT CHANGE IN PHYSICAL AND ENVIRONMENTAL HEALTH. PARTIAL MEDIATION BETWEEN YBLI INTERVENTION AND PHYSICAL HRQOL DOMAIN WAS OBSERVED VIA ADIPONECTIN. IN CONCLUSION, A 12-WEEK YBLI HAS A POSITIVE AND GREATER EFFECT ON HRQOL PHYSICAL DOMAIN SCORE THAN FOLLOWING DI ALONE. CHANGES IN BMI, ADIPONECTIN, AND SOD LEVELS MAY PREDICT CHANGES IN HRQOL DOMAINS AFTER LIFESTYLE INTERVENTION.	2021	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
10 1059  31 EFFECTS OF YOGA ON EXERCISE CAPACITY IN PATIENTS WITH LYMPHANGIOLEIOMYOMATOSIS: A NONRANDOMIZED CONTROLLED STUDY. OBJECTIVE: TO EVALUATE THE EFFECTS OF YOGA ON EXERCISE CAPACITY AND QUALITY OF LIFE IN PATIENTS WITH LYMPHANGIOLEIOMYOMATOSIS (LAM), A RARE CYSTIC LUNG DISEASE IN WOMEN. PATIENTS AND METHODS: THIS WAS A NONRANDOMIZED, CONTROLLED STUDY CONDUCTED IN BEIJING, CHINA (AUGUST 27, 2017 - APRIL 26, 2018). TWENTY-SIX PARTICIPANTS WERE ALLOCATED TO THE INTERVENTION (YOGA) GROUP (N = 13) OR CONTROL GROUP (N = 13). THE YOGA INTERVENTION INVOLVED A 24-WEEK PROGRAM OF YOGA CLASS TRAINING FOR 90 MIN ONCE A WEEK AND NO FEWER THAN 2 AT-HOME SESSIONS PER WEEK (AT LEAST 15 MIN PER SESSION). THE 6-MIN WALKING DISTANCE (6MWD), LUNG FUNCTION, SERUM VASCULAR ENDOTHELIAL GROWTH FACTOR-D (VEGF-D) LEVELS, QUALITY OF LIFE, AND SYMPTOMS OF ANXIETY AND DEPRESSION WERE MEASURED AT BASELINE, 12-WEEK AND 24-WEEK FOLLOW-UP. AN INCREMENTAL CARDIOPULMONARY EXERCISE TEST WAS CONDUCTED AT BASELINE AND THE 24-WEEK FOLLOW-UP. RESULTS: ELEVEN PATIENTS COMPLETED THE YOGA TRAINING PROGRAM. THE YOGA GROUP EXHIBITED IMPROVEMENTS IN THE FOLLOWING OUTCOMES VERSUS THOSE OF THE CONTROL GROUP: 6MWD (+ 55 +/- 29 M VS + 18 +/- 49 M, P = 0.04), ANAEROBIC THRESHOLD (3.4 +/- 2.4 ML/MIN/KG VS 1.6 +/- 1.4 ML/MIN/KG, P = 0.035) AND PEAK WORK LOAD (11.7 +/- 14.6 W VS 0.2 +/- 9.1 W, P = 0.027). THERE WAS NO SIGNIFICANT DIFFERENCE IN PEAK OXYGEN CONSUMPTION (VO2PEAK), LUNG FUNCTION, VEGF-D LEVEL, AND QUALITY OF LIFE BETWEEN THE YOGA AND CONTROL GROUPS. NO ADVERSE EFFECTS WERE FOUND IN THE YOGA GROUP. CONCLUSION: YOGA IS A FEASIBLE AND SAFE INTERVENTION FOR PULMONARY REHABILITATION AND POTENTIALLY IMPROVES EXERCISE CAPACITY IN PATIENTS WITH LAM. TRIAL REGISTRATION: (CLINICAL TRIAL REGISTRATION NUMBER AT WWW.CHICTR.ORG.CN: CHICTR-OON-1701274).	2020	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
11  779  38 EFFECT OF YOGA AS ADD-ON THERAPY IN MIGRAINE (CONTAIN): A RANDOMIZED CLINICAL TRIAL. OBJECTIVE: TO EVALUATE THE EFFECTIVENESS OF YOGA AS AN ADJUVANT TO CONVENTIONAL MEDICAL MANAGEMENT ON CLINICAL OUTCOMES IN PATIENTS WITH MIGRAINE. METHODS: CONTAIN WAS A PROSPECTIVE, RANDOMIZED, OPEN-LABEL SUPERIORITY TRIAL WITH BLINDED ENDPOINT ASSESSMENT CARRIED OUT AT A SINGLE TERTIARY CARE ACADEMIC HOSPITAL IN NEW DELHI, INDIA. PATIENTS ENROLLED WERE AGED 18-50 YEARS WITH A DIAGNOSIS OF EPISODIC MIGRAINE AND WERE RANDOMIZED INTO MEDICAL AND YOGA GROUPS (1:1). RANDOMIZATION WAS COMPUTER-GENERATED WITH A VARIABLE BLOCK SIZE AND CONCEALED. A PREDESIGNED YOGA INTERVENTION WAS GIVEN FOR 3 MONTHS. OUTCOMES WERE RECORDED BY A BLINDED ASSESSOR. THE PRIMARY ENDPOINT WAS A DECREASE IN HEADACHE FREQUENCY, HEADACHE INTENSITY, AND HEADACHE IMPACT TEST (HIT)-6 SCORE. SECONDARY OUTCOMES INCLUDED CHANGE IN MIGRAINE DISABILITY ASSESSMENT (MIDAS) SCORE, PILL COUNT, AND PROPORTION OF HEADACHE FREE PATIENTS. RESULTS: BETWEEN APRIL 2017 AND AUGUST 2018, 160 PATIENTS WITH EPISODIC MIGRAINE WERE RANDOMLY ASSIGNED TO MEDICAL AND YOGA GROUPS. A TOTAL OF 114 PATIENTS COMPLETED THE TRIAL. BASELINE MEASURES WERE COMPARABLE EXCEPT FOR A HIGHER MEAN HEADACHE FREQUENCY IN THE YOGA GROUP. COMPARED TO MEDICAL THERAPY, THE YOGA GROUP SHOWED A SIGNIFICANT MEAN DELTA VALUE REDUCTION IN HEADACHE FREQUENCY (DELTA DIFFERENCE 3.53 [95% CONFIDENCE INTERVAL 2.52-4.54]; P < 0.0001), HEADACHE INTENSITY (1.31 [0.60-2.01]; P = 0.0004), HIT SCORE (8.0 [4.78-11.22]; P < 0.0001), MIDAS SCORE (7.85 [4.98-10.97]; P < 0.0001), AND PILL COUNT (2.28 [1.06-3.51]; P < 0.0003). CONCLUSION: YOGA AS AN ADD-ON THERAPY IN MIGRAINE IS SUPERIOR TO MEDICAL THERAPY ALONE. IT MAY BE USEFUL TO INTEGRATE A COST-EFFECTIVE AND SAFE INTERVENTION LIKE YOGA INTO THE MANAGEMENT OF MIGRAINE. CLINICALTRIALSGOV IDENTIFIER: CTRI/2017/03/008041. CLASSIFICATION OF EVIDENCE: THIS STUDY PROVIDES CLASS III EVIDENCE THAT FOR PATIENTS WITH EPISODIC MIGRAINE, YOGA AS ADJUVANT TO MEDICAL THERAPY IMPROVES HEADACHE FREQUENCY, INTENSITY, IMPACT, AND DISABILITY.	2020	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
12 1034  35 EFFECTS OF YOGA IN DAILY LIFE PROGRAM IN RHEUMATOID ARTHRITIS: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVES: TO EXPLORE THE FEASIBILITY AND EFFECTIVENESS OF A YOGA PROGRAM IN IMPROVING HEALTH-RELATED QUALITY OF LIFE (HQOL), PHYSICAL AND PSYCHOLOGICAL FUNCTIONING IN RHEUMATOID ARTHRITIS (RA) PATIENTS. DESIGN: SINGLE-CENTRE PARALLEL-ARMS RANDOMIZED CONTROLLED TRIAL COMPARING YOGA (N = 30) AND EDUCATION CONTROL GROUP (N = 27). SETTING: TERTIARY CARE UNIVERSITY HOSPITAL. INTERVENTION: A 12-WEEK YOGA PROGRAM, BASED ON THE YOGA IN DAILY LIFE SYSTEM, INCLUDED 2X WEEKLY/90-MINUTE SESSIONS. THE CONTROL GROUP HAD 1XWEEKLY/60-MINUTE EDUCATIONAL LECTURES ON ARTHRITIS-RELATED TOPICS. MAIN OUTCOME MEASURES: ASSESSMENTS WERE PERFORMED AT BASELINE, 12 (POST-INTERVENTION) AND 24 WEEKS (FOLLOW-UP). THE PRIMARY OUTCOME WAS CHANGE IN THE SHORT FORM-36 (SF-36) HQOL AT 12 WEEKS. LINEAR REGRESSION ANALYSIS WAS ADJUSTED FOR BASELINE SCORES. RESULTS: NO SIGNIFICANT BETWEEN-GROUP DIFFERENCES WERE FOUND FOR SF-36 (ALL P > 0.05). AT 12 WEEKS THE ADJUSTED MEAN DIFFERENCE BETWEEN GROUPS FAVOURED YOGA FOR FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY-FATIGUE (5.08 CI 1.29 TO 8.86; P = 0.009) AND HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS)-DEPRESSION (-1.37 CI -2.38 TO -0.36); P = 0.008) AND AT 24 WEEKS FOR HADS-ANXIETY (-1.79 CI -3.34 TO - 0.23; P = 0.025), WHILE THE IMPACT ON FATIGUE WAS SUSTAINED (5.43 CI 1.33 TO 9.54, P = 0.01). THE PROGRAM HAD NO IMPACT ON RA DISEASE ACTIVITY. FEASIBILITY OUTCOMES INCLUDED RECRUITMENT RATE 16 %, RETENTION 80.7 %, AND ADHERENCE TO YOGA 87.5 VS 82.7 % FOR CONTROL. NO SERIOUS ADVERSE EVENTS WERE RECORDED. CONCLUSIONS: YOGA IN DAILY LIFE PROGRAM WAS NOT ASSOCIATED WITH CHANGE IN HEALTH-RELATED QUALITY OF LIFE OF RA PATIENTS. SIGNIFICANT IMPROVEMENTS IN FATIGUE AND MOOD WERE OBSERVED AT POSTINTERVENTION AND FOLLOW-UP. THIS YOGA PROGRAM WAS FOUND FEASIBLE AND SAFE FOR PATIENTS AND MAY COMPLEMENT STANDARD RA TREAT-TO-TARGET STRATEGY.	2021	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
13 1136  36 EFFICACY OF YOGA ON PREGNANCY OUTCOME. OBJECTIVE: TO STUDY THE EFFICACY OF YOGA ON PREGNANCY OUTCOMES. DESIGN AND SETTING: THREE HUNDRED THIRTY FIVE (335) WOMEN ATTENDING THE ANTENATAL CLINIC AT GUNASHEELA SURGICAL AND MATERNITY HOSPITAL IN BANGALORE, INDIA, WERE ENROLLED BETWEEN 18 AND 20 WEEKS OF PREGNANCY IN A PROSPECTIVE, MATCHED, OBSERVATIONAL STUDY; 169 WOMEN IN THE YOGA GROUP AND 166 WOMEN IN THE CONTROL GROUP. METHODS: WOMEN WERE MATCHED FOR AGE, PARITY, BODY WEIGHT, AND DOPPLER VELOCIMETRY SCORES OF UMBILICAL AND UTERINE ARTERIES. YOGA PRACTICES, INCLUDING PHYSICAL POSTURES, BREATHING, AND MEDITATION WERE PRACTICED BY THE YOGA GROUP ONE HOUR DAILY, FROM THE DATE OF ENTRY INTO THE STUDY UNTIL DELIVERY. THE CONTROL GROUP WALKED 30 MINUTES TWICE A DAY (STANDARD OBSTETRIC ADVICE) DURING THE STUDY PERIOD. COMPLIANCE IN BOTH GROUPS WAS ENSURED BY FREQUENT TELEPHONE CALLS AND STRICT MAINTENANCE OF AN ACTIVITY DIARY. MAIN OUTCOMES: BIRTH WEIGHT AND GESTATIONAL AGE AT DELIVERY WERE PRIMARY OUTCOMES. RESULTS: THE NUMBER OF BABIES WITH BIRTH WEIGHT > OR = 2500 GRAMS WAS SIGNIFICANTLY HIGHER (P < 0.01) IN THE YOGA GROUP. PRETERM LABOR WAS SIGNIFICANTLY LOWER (P < 0.0006) IN THE YOGA GROUP. COMPLICATIONS SUCH AS ISOLATED INTRAUTERINE GROWTH RETARDATION (IUGR) (P < 0.003) AND PREGNANCY-INDUCED HYPERTENSION (PIH) WITH ASSOCIATED IUGR (P < 0.025) WERE ALSO SIGNIFICANTLY LOWER IN THE YOGA GROUP. THERE WERE NO SIGNIFICANT ADVERSE EFFECTS NOTED IN THE YOGA GROUP. CONCLUSIONS: AN INTEGRATED APPROACH TO YOGA DURING PREGNANCY IS SAFE. IT IMPROVES BIRTH WEIGHT, DECREASES PRETERM LABOR, AND DECREASES IUGR EITHER IN ISOLATION OR ASSOCIATED WITH PIH, WITH NO INCREASED COMPLICATIONS.	2005	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
14  508  29 COMPARATIVE EFFICACY OF A 12 WEEK YOGA-BASED LIFESTYLE INTERVENTION AND DIETARY INTERVENTION ON ADIPOKINES, INFLAMMATION, AND OXIDATIVE STRESS IN ADULTS WITH METABOLIC SYNDROME: A RANDOMIZED CONTROLLED TRIAL. THE PRESENT RANDOMIZED CONTROLLED TRIAL (RCT) EVALUATED THE COMPARATIVE EFFICACY OF 12 WEEK YOGA-BASED LIFESTYLE INTERVENTION (YBLI) AND DIETARY INTERVENTION (DI) ALONE ON ADIPOKINES, INFLAMMATION, AND OXIDATIVE STRESS IN INDIAN ADULTS WITH METABOLIC SYNDROME (MET S). A PARALLEL, TWO ARM, RCT WAS CONDUCTED IN INTEGRAL HEALTH CLINIC (IHC), ALL INDIA INSTITUTE OF MEDICAL SCIENCES, INDIA FROM 2012 TO 2014. IHC IS AN OUTPATIENT FACILITY CONDUCTING YBLI PROGRAMS FOR PREVENTION AND MANAGEMENT OF CHRONIC DISEASES. TWO HUNDRED SIXTY MEN AND WOMEN (20-45 YEARS) VISITING THE OUTPATIENT DEPARTMENT OF A TERTIARY CARE HOSPITAL WERE DIAGNOSED WITH MET S AND RANDOMIZED 1:1 TO RECEIVE 12 WEEK YBLI (N = 130) OR DI (N = 130). PRIMARY OUTCOMES WERE CHANGE IN PLASMA LEVELS OF ADIPOKINES (LEPTIN, ADIPONECTIN, AND LEPTIN:ADIPONECTIN RATIO), MARKERS OF INFLAMMATION (TUMOR NECROSIS FACTOR [TNF]-ALPHA, INTERLEUKIN [IL]-6), MARKERS OF OXIDATIVE STRESS (THIOBARBITURIC ACID REACTIVE SUBSTANCES [TBARS], 8-HYDROXY-2'-DEOXYGUANOSINE [8-OHDG], AND SUPEROXIDE DISMUTASE [SOD]) MEASURED AT BASELINE, 2 WEEKS, AND 12 WEEKS. YBLI GROUP SHOWED A SIGNIFICANT DECREASE IN LEPTIN, LEPTIN:ADIPONECTIN RATIO, IL-6, 8-OHDG, AND TBARS LEVELS, WHEREAS THERE WAS A SIGNIFICANT INCREASE IN ADIPONECTIN AND SOD LEVELS. NO SIGNIFICANT CHANGES WERE NOTICED IN DI ALONE GROUP. YBLI SHOWED SIGNIFICANTLY GREATER REDUCTION IN TBARS LEVELS THAN IN DI GROUP, SUGGESTIVE OF REDUCED OXIDATIVE STRESS IN ADULTS WITH MET S. A 12 WEEK YBLI HAD A POSITIVE IMPACT ON OXIDATIVE STRESS VERSUS DI ALONE IN ADULTS WITH MET S.	2019	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
15 1497  41 INTRADIALYTIC LAUGHTER YOGA THERAPY FOR HAEMODIALYSIS PATIENTS: A PRE-POST INTERVENTION FEASIBILITY STUDY. BACKGROUND: LAUGHTER YOGA CONSISTS OF PHYSICAL EXERCISE, RELAXATION TECHNIQUES AND SIMULATED VIGOROUS LAUGHTER. IT HAS BEEN ASSOCIATED WITH PHYSICAL AND PSYCHOLOGICAL BENEFITS FOR PEOPLE IN DIVERSE CLINICAL AND NON-CLINICAL SETTINGS, BUT HAS NOT YET BEEN TESTED IN A HAEMODIALYSIS SETTING. THE STUDY HAD THREE AIMS: 1) TO EXAMINE THE FEASIBILITY OF CONDUCTING LAUGHTER YOGA FOR PATIENTS WITH END STAGE KIDNEY DISEASE IN A DIALYSIS SETTING; 2) TO EXPLORE THE PSYCHOLOGICAL AND PHYSIOLOGICAL IMPACT OF LAUGHTER YOGA FOR THESE PATIENTS; AND 3) TO ESTIMATE THE SAMPLE SIZE REQUIRED FOR FUTURE RESEARCH. METHODS: PRE/POST INTERVENTION FEASIBILITY STUDY. EIGHTEEN PARTICIPANTS WERE RECRUITED INTO THE STUDY AND LAUGHTER YOGA THERAPISTS PROVIDED A FOUR WEEK INTRADIALYTIC PROGRAM (30-MIN INTERVENTION THREE TIMES PER WEEK). PRIMARY OUTCOMES WERE PSYCHOLOGICAL ITEMS MEASURED AT THE FIRST AND LAST LAUGHTER YOGA SESSION, INCLUDING: QUALITY OF LIFE; SUBJECTIVE WELLBEING; MOOD; OPTIMISM; CONTROL; SELF-ESTEEM; DEPRESSION, ANXIETY AND STRESS. SECONDARY OUTCOMES WERE: BLOOD PRESSURE, INTRADIALYTIC HYPOTENSIVE EPISODES AND LUNG FUNCTION (FORCED EXPIRATORY VOLUME). DIALYSIS NURSES EXPOSED TO THE INTERVENTION COMPLETED A LAUGHTER YOGA ATTITUDES AND PERCEPTIONS SURVEY (N = 11). DATA WERE ANALYSED USING IBM SPSS STATISTICS V22, INCLUDING DESCRIPTIVE AND INFERENTIAL STATISTICS, AND SAMPLE SIZE ESTIMATES WERE CALCULATED USING G*POWER. RESULTS: ONE PARTICIPANT WITHDREW FROM THE STUDY FOR MEDICAL REASONS THAT WERE UNRELATED TO THE STUDY DURING THE FIRST WEEK (94 % RETENTION RATE). THERE WERE NON-SIGNIFICANT INCREASES IN HAPPINESS, MOOD, AND OPTIMISM AND A DECREASE IN STRESS. EPISODES OF INTRADIALYTIC HYPOTENSION DECREASED FROM 19 PRE AND 19 DURING LAUGHTER YOGA TO 4 POST LAUGHTER YOGA. THERE WAS NO CHANGE IN LUNG FUNCTION OR BLOOD PRESSURE. ALL NURSES AGREED OR STRONGLY AGREED THAT LAUGHTER YOGA HAD A POSITIVE IMPACT ON PATIENTS' MOOD, IT WAS A FEASIBLE INTERVENTION AND THEY WOULD RECOMMEND LAUGHTER YOGA TO THEIR PATIENTS. SAMPLE SIZE CALCULATIONS FOR FUTURE RESEARCH INDICATED THAT A MINIMUM OF 207 PARTICIPANTS WOULD BE REQUIRED TO PROVIDE SUFFICIENT POWER TO DETECT CHANGE IN KEY PSYCHOLOGICAL VARIABLES. CONCLUSIONS: THIS STUDY PROVIDES EVIDENCE THAT LAUGHTER YOGA IS A SAFE, LOW-INTENSITY FORM OF INTRADIALYTIC PHYSICAL ACTIVITY THAT CAN BE SUCCESSFULLY IMPLEMENTED FOR PATIENTS IN DIALYSIS SETTINGS. LARGER STUDIES ARE REQUIRED, HOWEVER, TO DETERMINE THE EFFECT OF LAUGHTER YOGA ON KEY PSYCHOLOGICAL VARIABLES. TRIAL REGISTRATION: AUSTRALIAN NEW ZEALAND CLINICAL TRIALS REGISTRY - ACTRN12614001130651 . REGISTERED 23 OCTOBER 2014.	2015	

16  798  43 EFFECT OF YOGA LIFESTYLE IN PATIENTS WITH HEART FAILURE: A RANDOMIZED CONTROL TRIAL. BACKGROUND: IN SPITE OF SIGNIFICANT ADVANCES IN THE MANAGEMENT OF HEART FAILURE (HF), MORBIDITY AND MORTALITY REMAIN HIGH. THEREFORE, THERE IS A NEED FOR ADDITIONAL STRATEGIES. WE DID A RANDOMIZED CLINICAL TRIAL TO STUDY EFFECT OF YOGA IN PATIENTS WITH HF IN TERMS OF QUALITY OF LIFE (QOL), LEFT VENTRICLE EJECTION FRACTION (LVEF), C-REACTIVE PROTEIN (CRP), AND NTPROBNP. MATERIALS AND METHODS: 60 PATIENTS WITH STABLE HF NEW YORK HEART ASSOCIATION CLASS II WITH LVEF 30%-40% WERE RANDOMIZED INTO CONTROL GROUP (CG) AND YOGA GROUP (YG). CG RECEIVED THE GUIDELINE-BASED THERAPY AND YG IN ADDITION PRACTICED THE YOGA, ONE HOUR DAILY FOR 3 MONTHS. ALL PATIENTS WERE ASSESSED FOR QOL, CRP, NTPROBNP, AND LVEF AT BASELINE AND AFTER 3 MONTHS. RESULTS: A SIGNIFICANT DIFFERENCE WAS OBSERVED IN ALL FOUR PARAMETERS IN THE YG AS COMPARED TO THE CG (P < 0.01) AFTER 12 WEEKS. QOL AS ASSESSED BY MINNESOTA LIVING WITH HEART FAILURE QUESTIONNAIRE SCORE IMPROVED SIGNIFICANTLY IN YG AS COMPARED TO CG (10 V/S 14, P < 0.001). THERE WAS A SIGNIFICANT IMPROVEMENT WITHIN YG IN TERMS OF LVEF (33.4-36.8, P = 0.001), AND THE PERCENTAGE CHANGE IN LVEF WAS SIGNIFICANT BETWEEN THE GROUPS (10% V/S 5%, P = 0.001). NTPROBNP ALSO SIGNIFICANTLY REDUCED BY 69.8% FROM 755 TO 220 PMOL/L IN YG AS COMPARED TO 39.3% IN CG (679-406 PMOL/L). CRP DECREASED BY 49.3% (5.36-2.73 MG/L) IN YG AND 35.8% (5.39-3.45 MG/L) IN CG. CONCLUSION: THE RESULT OF THIS PILOT STUDY SUGGESTS THAT ADDITION OF YOGA TO GUIDELINE-BASED THERAPY FOR HF PATIENTS SIGNIFICANTLY IMPROVES QOL, LVEF, AND NTPROBNP AND REDUCES CRP LEVEL. LARGER STUDIES ARE NEEDED TO CONFIRM THESE FINDINGS.	2022	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
17  166  28 A RANDOMIZED CONTROL TRIAL TO STUDY THE EFFECT OF INTEGRATED YOGA ON PREGNANCY OUTCOME IN HYPERTENSIVE DISORDER OF PREGNANCY. OBJECTIVE: THE STUDY AIMED TO EVALUATE THE EFFECTS OF INTEGRATED YOGA ON BLOOD PRESSURE AND PREGNANCY OUTCOME IN HYPERTENSIVE DISORDER OF PREGNANCY. METHODS: SEVENTY-NINE PATIENTS WERE RANDOMIZED INTO STUDY AND CONTROL GROUPS. THE STUDY GROUP RECEIVED THE INTERVENTION IN THE FORM OF INTEGRATED YOGA FOR 4 WEEKS. FINAL ANALYSIS WAS DONE ON 30 PATIENTS EACH OF STUDY AND CONTROL GROUP. RESULTS: THE MEAN SYSTOLIC BP DECLINED BY 7.43 +/- 5.86 MMHG IN THE STUDY GROUP AS COMPARED TO 2.50 +/- 5.21 MM HG IN THE CONTROL GROUP (P VALUE 0.002). THE MEAN DIASTOLIC BP PRIOR TO DELIVERY WAS 88.00 +/- 3.71 MMHG IN THE STUDY GROUP AND 92.20 +/- 5.02 MMHG IN THE CONTROL GROUP (P = 0.001). THE MATERNAL COMFORT IN LABOR WAS SIGNIFICANTLY HIGHER AND THE DURATION OF LABOR SIGNIFICANTLY REDUCED IN THE STUDY GROUP. CONCLUSION: INTEGRATED YOGA EFFECTIVELY REDUCED SYSTOLIC AND DIASTOLIC BLOOD PRESSURES AND INCREASED MATERNAL COMFORT DURING LABOR IN HYPERTENSIVE DISORDER OF PREGNANCY.	2021	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
18  692  38 EFFECT OF COMMUNITY-BASED YOGA INTERVENTION ON OXIDATIVE STRESS AND GLYCEMIC PARAMETERS IN PREDIABETES: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVES: TO STUDY THE EFFECTIVENESS OF YOGA INTERVENTION ON OXIDATIVE STRESS, GLYCEMIC STATUS, BLOOD PRESSURE AND ANTHROPOMETRY IN PREDIABETES. DESIGN: RANDOMIZED-CONTROLLED TRIAL. PARTICIPANTS: TWENTY NINE PREDIABETES SUBJECTS AGED 30-75 YEARS. SETTING: YOGA WAS CONDUCTED AT 4 DIFFERENT COMMUNITY DIABETES CLINICS IN MANGALORE, INDIA. INTERVENTIONS: PARTICIPANTS WERE RANDOMIZED TO EITHER 3-MONTH YOGA OR WAIT-LIST CONTROL GROUPS. MAIN OUTCOME MEASURES: MALONDIALDEHYDE, GLUTATHIONE, VITAMIN C, VITAMIN E, SUPEROXIDE DISMUTASE, PLASMA GLUCOSE, GLYCATED HAEMOGLOBIN, BMI, WAIST CIRCUMFERENCE, WAIST-TO-HIP RATIO AND BLOOD PRESSURE. RESULTS: YOGA INTERVENTION RESULTED IN A SIGNIFICANT DECLINE IN MALONDIALDEHYDE (P<0.001), RELATIVE TO THE CONTROL GROUP. IN COMPARISON WITH THE CONTROL, THERE WAS A SIGNIFICANT IMPROVEMENT IN BMI, WAIST CIRCUMFERENCE, SYSTOLIC BLOOD PRESSURE AND FASTING GLUCOSE LEVELS AT FOLLOW-UP. NO SIGNIFICANT IMPROVEMENT IN GLYCATED HAEMOGLOBIN, WAIST-TO-HIP RATIO OR ANY OF THE ANTIOXIDANTS WAS OBSERVED. CONCLUSIONS: YOGA INTERVENTION MAY BE HELPFUL IN CONTROL OF OXIDATIVE STRESS IN PREDIABETES SUBJECTS. YOGA CAN ALSO BE BENEFICIAL IN REDUCTION IN BMI, WAIST CIRCUMFERENCE, SYSTOLIC BLOOD PRESSURE AND FASTING GLUCOSE. EFFECT OF YOGA ON ANTIOXIDANT PARAMETERS WAS NOT EVIDENT IN THIS STUDY. THE FINDINGS OF THIS STUDY NEED TO BE CONFIRMED IN LARGER TRIALS INVOLVING ACTIVE CONTROL GROUPS.	2013	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
19 1797  38 PRENATAL YOGA: EFFECTS ON ALLEVIATION OF LABOR PAIN AND BIRTH OUTCOMES. BACKGROUND: THIS STUDY WAS CONDUCTED TO TEST THE HYPOTHESIS THAT PRENATAL YOGIC EXERCISES ARE EFFECTIVE IN ALLEVIATING LABOR PAIN AND IMPROVING BIRTH OUTCOMES, BY COMPARING PREGNANT WOMEN UNDERTAKING YOGA WITH A CONTROL GROUP. TRIAL DESIGN: SINGLE BLINDED, PARALLEL RANDOMIZED CONTROL TRIAL. METHODS: TWO HUNDRED PRIMIGRAVID WOMEN OF 30 WEEKS OF GESTATION ONWARD WHO MET THE INCLUSION CRITERIA (PRIMIGRAVIDA, 20-35 YEARS OF AGE, GESTATIONAL AGE OF 30 WEEKS, NO PRIOR EXPERIENCE OF YOGA) WERE RANDOMLY ASSIGNED TO STUDY (N = 100) AND CONTROL GROUPS (N = 100) BY USING THE MINIMIZED RANDOMIZATION PROGRAM VERSION 2.01. THE STUDY GROUP RECEIVED THE INTERVENTION IN THE FORM OF INTEGRATED YOGA CONSISTING OF A SERIES OF 30-MIN PRACTICE SESSIONS AT THE 30TH, 32ND, 34TH, 36TH, 37TH, 38TH, AND 39TH WEEKS OF GESTATIONAL AGE. THE MATCHED CONTROL GROUP DID NOT PERFORM YOGA. THE PATIENTS WERE FOLLOWED TILL DELIVERY FOR MATERNAL COMFORT, ALLEVIATION OF LABOR PAIN, AND BIRTH OUTCOME. ALLEVIATION OF LABOR PAIN WAS ASSESSED BY USING NUMERICAL PAIN INTENSITY SCALE (NPIS), PAIN BEHAVIORAL OBSERVATIONAL SCALE (PBOS), AND MATERNAL DELIVERY COMFORT QUESTIONNAIRE. ONLY THE ASSESSORS WERE BLINDED. RESULTS: TWO HUNDRED PATIENTS WERE RANDOMIZED INTO 100 EACH IN CASE AND CONTROL GROUPS. FINAL ANALYSIS WAS DONE ON 75 PATIENTS IN EACH GROUP AFTER EXCLUSION DUE TO DEVELOPMENT OF COMPLICATIONS, LOSS TO FOLLOW-UP. THE REQUIREMENT OF INDUCTION OF LABOR AND ANALGESICS WAS SIGNIFICANTLY LESS IN THE STUDY GROUP (P < 0.044, P < 0.045). THERE WAS SIGNIFICANTLY MORE NUMBER OF NORMAL VAGINAL DELIVERIES (P < 0.037) AND LESS CAESAREAN SECTIONS (P < 0.048), SHORTER FIRST STAGE OF LABOR (P < 0.0003) IN THE STUDY GROUP PRACTICING YOGA. THE TOLERANCE OF PAIN WAS BETTER IN THE STUDY GROUP AS SHOWN BY NPIS (P < 0.001) AND PBOS SCORES (P < 0.0001). POSTPARTUM, THE MATERNAL COMFORT QUESTIONNAIRE SCORE SHOWED HIGHER COMFORT IN THE STUDY GROUP (P < 0.032). THE NUMBER OF LOW BIRTH WEIGHT BABIES WAS ALSO SIGNIFICANTLY LESS IN THE STUDY GROUP (P < 0.042). THERE WERE NO ADVERSE EFFECTS ATTRIBUTED TO YOGA. CONCLUSION: THE STUDY HAS HIGHLIGHTED THAT YOGA IS A NONINVASIVE, EASY TO LEARN MIND-BODY MEDICINE AND COMPLEMENTARY HEALTH PRACTICE, EFFECTIVE IN ALLEVIATION OF LABOR PAIN AND POSSIBLY IMPROVING BIRTH OUTCOME.	2018	
                                                                                                                                                                                                                                                                                                                                                                                              
20  910  39 EFFECTIVENESS OF HATHA YOGA VERSUS CONVENTIONAL THERAPEUTIC EXERCISES FOR CHRONIC NONSPECIFIC LOW-BACK PAIN. OBJECTIVE: TO DETERMINE WHETHER THE EFFECTIVENESS OF HATHA YOGA THERAPY IS COMPARABLE TO CONVENTIONAL THERAPEUTIC EXERCISES (CTES) FOR REDUCING BACK PAIN INTENSITY AND BACK-RELATED DYSFUNCTION IN PATIENTS WITH CHRONIC NONSPECIFIC LOW-BACK PAIN (CNLBP). DESIGN: THE STUDY WAS A PROSPECTIVE RANDOMIZED COMPARATIVE TRIAL, DIVIDED INTO TWO PHASES: AN INITIAL 6-WEEKLY SUPERVISED INTERVENTION PERIOD FOLLOWED BY A 6-WEEK FOLLOW-UP PERIOD. SETTINGS: THIS STUDY WAS CONDUCTED AT DEPARTMENT OF PHYSICAL MEDICINE AND REHABILITATION AND CENTRE FOR INTEGRATIVE MEDICINE AND RESEARCH OF A TERTIARY CARE HOSPITAL. SUBJECTS: PATIENTS BETWEEN 18 AND 55 YEARS OF AGE WITH COMPLAINT OF CNLBP PERSISTING >/=12 WEEKS WITH PAIN RATING >/=4 ON A NUMERICAL RATING SCALE (0-10). INTERVENTION: A TOTAL OF SIX STANDARDIZED 35-MIN WEEKLY HATHA YOGA SESSIONS (YOGA GROUP) AND SIMILARLY 35-MIN WEEKLY SESSIONS OF CTES (CTE GROUP), DESIGNED FOR PEOPLE WITH CNLBP UNACCUSTOMED TO STRUCTURED YOGA OR CTE PROGRAM. PARTICIPANTS WERE ASKED TO PRACTICE ON NONCLASS DAYS AT HOME. OUTCOME MEASURES: THE PRIMARY OUTCOME MEASURES WERE DEFENSE AND VETERANS PAIN RATING SCALE (DVPRS) (0-10) AND 24-POINT ROLAND MORRIS DISABILITY QUESTIONNAIRE (RDQ). SECONDARY OUTCOMES WERE PAIN MEDICATION USAGE PER WEEK AND A POSTINTERVENTION PERCEIVED RECOVERY (LIKERT SEVEN-POINT SCALE) OF BACK-RELATED DYSFUNCTION. OUTCOMES WERE RECORDED AT THE BASELINE, 6-WEEK FOLLOW-UP, AND 12-WEEK FOLLOW-UP. RESULTS: SEVENTY SUBJECTS WERE RANDOMIZED TO EITHER YOGA (N = 35) OR CTE GROUP (N = 35). DATA WERE ANALYZED USING INTENTION-TO-TREAT, WITH LAST OBSERVATION CARRIED FORWARD. BOTH YOGA AND THE CTE GROUP HAVE SHOWN SIGNIFICANT IMPROVEMENT IN BACK PAIN INTENSITY AND BACK-RELATED DYSFUNCTION WITHIN BOTH THE GROUPS AT 6- AND 12-WEEK FOLLOW-UPS COMPARED TO BASELINE. NO STATISTICALLY SIGNIFICANT DIFFERENCES IN THE PAIN INTENSITY (DVPRS; AT 6 WEEKS: N = 35, DIFFERENCE OF MEDIANS 1.0, 95% CONFIDENCE INTERVAL [-5.3 TO 3.0], P = 0.5; AT 12 WEEKS: N = 35, 0.0 [-4.2 TO 5.0], 0.7) AND BACK-RELATED DYSFUNCTION (RDQ; AT 6 WEEKS: N = 35, 1.0 [-9.6 TO 10.6], 0.4; AT 12 WEEKS: N = 35, 0.0 [-8.8 TO 10.6], 0.3) WERE NOTED BETWEEN TWO GROUPS. IMPROVEMENTS IN PILL CONSUMPTION AND PERCEIVED RECOVERY WERE ALSO COMPARABLE BETWEEN THE GROUPS. CONCLUSION: YOGA PROVIDED SIMILAR IMPROVEMENT COMPARED WITH CTES, IN PATIENTS WITH CNLBP.	2019